Mia's Feed
Medical News & Research

Research Shows Allergy Shots Are Effective Regardless of Dose or Allergy Severity

Research Shows Allergy Shots Are Effective Regardless of Dose or Allergy Severity

Share this article

Recent research shows that allergy immunotherapy works effectively regardless of allergen dose or allergy severity, paving the way for personalized allergy treatments.

2 min read

Allergy immunotherapy, commonly known as allergy shots, is a treatment used by approximately 2.6 million Americans each year to combat allergies to substances like peanuts, bees, pollen, and cockroaches. These therapies have been in use for decades and are generally considered both safe and effective. However, scientists still aim to understand precisely how these treatments work and what factors influence their success.

Research conducted by scientists at the La Jolla Institute for Immunology (LJI) has provided new insights into the actual mechanisms behind allergy immunotherapy. They focus on how these treatments target specific immune cells, particularly T cells, which play a crucial role in driving allergic reactions. T cells "remember" previous exposures to allergens and alert other immune cells when allergens are detected.

A recent study examined how different doses of allergens in immunotherapy affect T cell responses, particularly in children aged 8 to 17 with cockroach allergies—a common issue in urban settings where up to 89% of households have cockroach allergens. Interestingly, the findings revealed that the concentration of allergens in the extracts did not significantly alter T cell responses, as long as key proteins were included. This suggests that the dosing may not be as critical as previously thought, provided the extract contains the relevant allergens.

The research highlighted a particular type of T cell known as Th2 cells, which are linked to asthma and allergic reactions. By targeting and desensitizing these cells, allergy treatments can effectively reduce symptoms. The studies further showed that immunotherapy works equally well in children with mild and severe allergies, indicating that the strength of a person's allergic response doesn't necessarily affect the therapy’s effectiveness.

These findings open the possibility for more refined, molecular-level allergy treatments in the future. Scientists aim to develop immunotherapies based on specific allergens and immune responses rather than crude allergen extracts, potentially leading to safer and more effective personalized therapies.

Overall, this research gives hope that allergy shots can be effective across a wide range of allergy severities and allergen doses, simplifying treatment protocols and broadening options for allergy sufferers.

Source: https://medicalxpress.com/news/2025-07-allergy-shots-dose-severity.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Opioid Testing Methods Promise Enhanced Treatment Strategies

Researchers from Brown University have developed advanced automated testing methods for detecting opioids in small blood samples and dried blood spots, promising significant improvements in opioid diagnosis and treatment, especially for newborns and individuals with opioid use disorder.

The Impact of Excessive Screen Time on Youth Heart Health

Excessive screen time among children and teens is linked to increased risks of early cardiometabolic issues, underscoring the importance of moderating leisure device use to promote long-term heart health.

Increased Risk of Rare Lymphoma in Breast Cancer Patients with BRCA Mutations and Textured Implants

Women with breast cancer carrying BRCA mutations who receive textured breast implants face a significantly higher risk of developing rare lymphoma, according to new research. The study underscores the importance of genetic testing and personalized healthcare in breast reconstruction decisions.

New Insights into the Origin of Lance-Adams Syndrome in the Motor Cortex

A groundbreaking study has identified the motor cortex as the source of myoclonus in Lance-Adams syndrome, paving the way for targeted therapies and improved patient care.